Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$78,000 |
 |
AmarinAMRN |
$410,000 |
 |
Gilead SciencesGILD |
-$1.19B |
 |
Anavex Life SciencesAVXL |
-$6.3M |
 |
AmgenAMGN |
-$98M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| BB BIOTECH AG | Mar 19, 2025 | Sell | 2,000,000 | $2.0004 | $4M |
| BB BIOTECH AG | Mar 19, 2025 | Sell | 1,000,000 | $2.3081 | $2.3M |
| BB BIOTECH AG | Mar 19, 2025 | Sell | 584,292 | $1.9532 | $1.1M |
| BB BIOTECH AG | Mar 19, 2025 | Sell | 500,000 | $2.1169 | $1.1M |
| BB BIOTECH AG | Mar 19, 2025 | Sell | 400,000 | $2.0929 | $840,000 |
| BB BIOTECH AG | Mar 19, 2025 | Sell | 300,000 | $1.943 | $580,000 |
| Versant Venture Capital VI, L.P. | Aug 28, 2024 | Sell | 221,600 | $6.3202 | $1.4M |
| BB BIOTECH AG | Oct 17, 2023 | Buy | 400,000 | $2.3352 | $930,000 |
What's the latest insider transaction for Black Diamond Therapeutics?
The most recent insider transaction for Black Diamond Therapeutics was conducted by BB BIOTECH AG, who sold 2,000,000 shares on March 19, 2025 at a price of $2.00 per share.
Which insider bought the most BDTX stock over the last two years?
BB BIOTECH AG has bought the most BDTX stock in the last 2 years, with a total value of $930,000.
Which insider has sold the most BDTX stock over the last two years?
BB BIOTECH AG has sold the most BDTX stock in the last 2 years, with a total value of $9.9M.
What is the total value of insider transactions for Black Diamond Therapeutics (BDTX) in the last 2 years?
The total value of insider transactions for Black Diamond Therapeutics in the last 2 years is negative, amounting to -$10M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Black Diamond Therapeutics' market confidence?
Over the last 2 years, insider transactions for Black Diamond Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
